The estimated Net Worth of Richard Koo is at least $12.9 Milión dollars as of 1 June 2021. Mr. Koo owns over 25,827 units of Amphastar Pharmaceuticals Inc stock worth over $12,578,902 and over the last 10 years he sold AMPH stock worth over $0. In addition, he makes $310,007 as Independent Director at Amphastar Pharmaceuticals Inc.
Sign up
Mr. Koo AMPH stock SEC Form 4 insiders trading
Richard has made over 4 trades of the Amphastar Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 25,827 units of AMPH stock worth $424,338 on 1 June 2021.
The largest trade he's ever made was exercising 47,782 units of Amphastar Pharmaceuticals Inc stock on 27 May 2020 worth over $721,986. On average, Richard trades about 8,982 units every 207 days since 2014. As of 1 June 2021 he still owns at least 279,097 units of Amphastar Pharmaceuticals Inc stock.
You can see the complete history of Mr. Koo stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Richard Koo biography
Richard Koo CPA serves as Independent Director of the Company. He has served as a member of our board of directors since August 2003 and also served as a member of our board of directors from January 1997 to February 2002. Mr. Koo has been the managing partner of Koo, Chow and Company, Certified Public Accountants since 1979, CEO and President of K.C. Group International Inc. since February 2003 and a previously served as director of EverTrust Bank from January 2009 until 2017. Prior to Koo, Chow and Company, Mr. Koo worked with PricewaterhouseCoopers LLP in various public offering audit assignments. Mr. Koo has worked as a finance and taxation expert for the United Nations. Mr. Koo received a B.S. in management from the National Taiwan University and an M.B.A. in accounting from San Jose State University.
What is the salary of Richard Koo?
As the Independent Director of Amphastar Pharmaceuticals Inc, the total compensation of Richard Koo at Amphastar Pharmaceuticals Inc is $310,007. There are 11 executives at Amphastar Pharmaceuticals Inc getting paid more, with Jack Zhang having the highest compensation of $5,969,740.
How old is Richard Koo?
Richard Koo is 79, he's been the Independent Director of Amphastar Pharmaceuticals Inc since 2002. There are no older and 16 younger executives at Amphastar Pharmaceuticals Inc.
What's Richard Koo's mailing address?
Richard's mailing address filed with the SEC is C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA,, CA, 91730.
Insiders trading at Amphastar Pharmaceuticals Inc
Over the last 10 years, insiders at Amphastar Pharmaceuticals Inc have traded over $72,457,295 worth of Amphastar Pharmaceuticals Inc stock and bought 66,100 units worth $921,987 . The most active insiders traders include Jack Y.Luo Mary Z. Zhang, Richard K Prins a William J Peters. On average, Amphastar Pharmaceuticals Inc executives and independent directors trade stock every 11 days with the average trade being worth of $1,459,051. The most recent stock trade was executed by Floyd F. Petersen on 5 September 2024, trading 3,000 units of AMPH stock currently worth $139,410.
What does Amphastar Pharmaceuticals Inc do?
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
What does Amphastar Pharmaceuticals Inc's logo look like?
Complete history of Mr. Koo stock trades at Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc executives and stock owners
Amphastar Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Jack Zhang,
President, Chief Executive Officer, Chief Scientific Officer, Director -
Mary Luo,
Chief Operating Officer, Chief Scientist and Chairman of the Board -
Dr. Yongfeng Zhang,
Co-founder, Pres, CEO, Chief Scientific Officer & Director -
William Peters,
Chief Financial Officer, Senior Vice President, Treasurer and President of International Medication Systems, Limited -
Dr. Ziping Luo,
Chairman, Chief Scientist & COO -
Rong Zhou,
Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc. -
William J. Peters M.B.A.,
CFO, Treasurer & Exec. VP of Fin. -
Rong Zhou,
Exec. VP of Production Center -
Jacob Liawatidewi M.B.A.,
Exec. VP of Corp. Admin. Center, Sales & Marketing and Corp. Sec. -
Diane Gerst,
Director -
Richard Prins,
Lead Independent Director -
Richard Koo,
Independent Director -
Howard Lee,
Independent Director -
Michael Zasloff,
Independent Director -
Floyd Petersen,
Independent Director -
Jacob Liawatidewi,
Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary -
Peter Langosh,
VP of Operational Improvement and VP of Internal Audit -
Tony Marrs,
Sr. VP of Regulatory Affairs and Clinical Operations -
Dan Dischner,
VP of Corp. Communications -
Stephen B. Shohet,
Director -
Gayle Deflin,
-
Physics & Chemistry Laborat...,
10% owner -
Mary Z.Zhang Jack Y. Luo,
COO,Chief Scientist & ChairmanCEO & Chief Scientific Officer -
Jason B. Shandell,
President and General Counsel -
Marilyn J. Purchase,
Corp. Exec. VP of Operations -
David Maris,
Director -
Jack Y.Luo Mary Z.Applied P...,
CEO & Chief Scientific OfficerCOO,Chief Scientist & Chairman -
Yakob Liawatidewi,
EVP CORP ADMIN CENTER